Blackstone’s Gritstone bio GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-8,761
Closed -$95K – 611
2021
Q3
$95K Buy
+8,761
New +$79.7K ﹤0.01% 542
2021
Q1
– Sell
-2,567,445
Closed -$10.1M – 525
2020
Q4
$10.1M Hold
2,567,445
– – 0.04% 109
2020
Q3
$6.8M Hold
2,567,445
– – 0.03% 110
2020
Q2
$17M Hold
2,567,445
– – 0.07% 60
2020
Q1
$14.9M Hold
2,567,445
– – 0.11% 38
2019
Q4
$23M Hold
2,567,445
– – 0.15% 19
2019
Q3
$22.2M Hold
2,567,445
– – 0.13% 22
2019
Q2
$28.6M Hold
2,567,445
– – 0.15% 23
2019
Q1
$34.1M Hold
2,567,445
– – 0.17% 23
2018
Q4
$39.7M Buy
+2,567,445
New +$49M 0.22% 19

Other funds holding GRTS

Blackstone's GRTS Position: Q4 2021 in Review

Blackstone sold out of Gritstone bio (GRTS) in Q4 2021, closing a stake of 8,761 shares — an estimated $95K sold.

Blackstone first reported a position in GRTS in Q4 2018 and held it in 10 quarters. The position peaked at $39.7M in Q4 2018. 115 funds tracked by Wall St. Rank hold GRTS as of Q4 2021.

  • Blackstone reported no remaining Gritstone bio position as of Q4 2021 after selling out during the quarter.
  • Blackstone sold 8,761 Gritstone bio shares in Q4 2021, an estimated $95K.
  • Blackstone first reported a position in Gritstone bio in Q4 2018 and held it in 10 quarters.
  • Blackstone's Gritstone bio position peaked at $39.7M in Q4 2018.
  • 115 funds tracked by Wall St. Rank held Gritstone bio as of Q4 2021.

Based on Blackstone's 13F filing for Q4 2021, filed 14 Feb 2022.